This medical condition has either been superseded or has become inactive
| Specific Conditions |
|
| Level of Evidence | Insufficient data (Category 4a) |
|
Intravenous immunoglobulin (IVIg) should be considered for severe cases refractory to conventional immunosuppressive therapy. Refer to the current product information sheet for further information. The aim should be to use the lowest dose possible that achieves the appropriate clinical outcome for each patient. |
|